Duration of Follow-Up and Treatment for Non-Insulin Antidiabetic Drugs

Project Title Duration of Follow-Up and Treatment for Non-Insulin Antidiabetic Drugs
Date Posted
Tuesday, April 2, 2019
Project ID
cder_mpl1r_wp099, cder_mpl1r_wp092
Status
Complete
Deliverables
Sentinel Modular Program Report: Duration of Follow-Up and Treatment for Non-Insulin Antidiabetic Drugs, Report 1
Sentinel Modular Program Report: Duration of Follow-Up and Treatment for Non-Insulin Antidiabetic Drugs, Report 2
Description

The goal of this request was to estimate the duration of use and duration of follow-up time for patients dispensed non-insulin antidiabetic drugs in the Sentinel Distributed Database (SDD). This request contains two reports: 

  • Report 1 estimates the length of follow-up time for patients diagnosed with Type 2 Diabetes and for patients dispensed non-insulin antidiabetic drugs. 
  • Report 2 summarizes utilization of non-insulin antidiabetic drugs available in the SDD. 

Data from January 1, 2008 to January 31, 2018 from 17 Data Partners contributing to the SDD were included in this report. This request was distributed to Data Partners on June 28, 2018.

Medical Product
non-insulin antidiabetics
Time Period
January 1, 2008 - January 31, 2018
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Sentinel Distributed Database (SDD)
FDA Center
CDER
Scroll to Top